Last reviewed · How we verify
NCT03372824
Glycated Albumin in Pregnancy
trial in Gestational Diabetes in 148 participants. Completed in 1 February 2019.
1 February 2019
Quick facts
| Lead sponsor | Helse Stavanger HF |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 148 |
| Start date | 1 November 2017 |
| Primary completion | 1 February 2019 |
| Estimated completion | 1 February 2019 |
| Sites | 1 location across Norway |
Conditions studied
- Gestational Diabetes — all drugs for Gestational Diabetes →
Sponsor
Helse Stavanger HF — full company profile →
Who can join
25 and older, female only, with Gestational Diabetes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is an observational study at the Obstetrical outpatient clinic at Stavanger University Hospital, Norway. The purpose of the study is to compare glycated albumin and glycated hemoglobin (HbA1c), both markers of "long-term blood sugar" with oral glucose tolerance test (OGTT). The OGTT is a screening test for gestational diabetes, a condition that increases risk of adverse pregnancy outcome for mother and child. The risks are reduced with good glycaemic control throughout pregnancy, therefore, it is important to screen for gestational diabetes.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Gestational diabetes mellitus follow-up in Norwegian primary health care: a qualitative study.
Toft JH, Økland I, Risa CF. · · 2022 · cited 10× · PMID 34880032 · DOI 10.3399/bjgpo.2021.0104
Verify or expand the search:
- PubMed search for NCT03372824
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Gestational Diabetes
Currently open trials in the same condition.
- NCT07171684 — Single vs Multi-Dose Insulin for Glycemic Control (SUGAR) · NA · recruiting
- NCT07314944 — Maternal Sleep and Lifestyle, Metabolic Health, and Perinatal Outcomes in Gestational Diabetes · recruiting
- NCT06571487 — Growth Hormone Resistance of Beta-cells · recruiting
- NCT07336914 — Effect of Conventional vs Intensive Management on Gestational Diabetes and Maternal Fetal Outcomes · NA · recruiting
- NCT07174245 — Pregnancy and Postpartum CGM in GDM · recruiting
Other Helse Stavanger HF trials
Trials by the same sponsor.
- NCT06983002 — Bridging Affect Consciousness, Mentalization and Trauma- Exploring an Integrative Treatment Approach for Personality Dis · NA · not yet recruiting
- NCT06774261 — Phenserine on the Alzheimer's Treatment Horizon, Study 1 · Phase 1 · not yet recruiting
- NCT06362707 — Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD) · Phase 2 · recruiting
- NCT06211907 — Small Macular Holes Treated With Air · NA · recruiting
- NCT06150274 — Comparison of Wire Assisted Percutaneous Balloon Mitral Valvulotomy With Standard Inoue Balloon Valvulotomy · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03372824 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Helse Stavanger HF
- Last refreshed: 27 January 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03372824.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing